Literature DB >> 20220108

Neutrophil expression of cyclooxygenase 2 in preeclampsia.

Teddi Bachawaty1, Sonya L Washington, Scott W Walsh.   

Abstract

The objective of this study was to determine whether (1) neutrophils of preeclamptic women express cyclooxygenase 2 (COX-2) and (2) COX-2 mediates neutrophil interleukin 8 (IL-8) production. Neutrophils were isolated from heparinized blood collected from women with preeclampsia and normal pregnancy and from normal nonpregnant women. Cyclooxygenase 2 protein was measured in the neutrophils of the 3 groups by specific enzyme-linked immunosorbent assay (ELISA). To study the role of COX-2 in IL-8 production, neutrophils of normal pregnant women were activated with arachidonic acid (AA) and incubated overnight in Medium 199 with and without NS398, a specific COX-2 inhibitor. We found that neutrophils from preeclamptic women expressed significantly more COX-2 than neutrophils from normal pregnant or normal nonpregnant women. Arachidonic acid activated neutrophils to produce IL-8, which was completely inhibited by NS398. These data demonstrate that COX-2 is expressed in neutrophils of preeclamptic women and that COX-2 mediates IL-8 production by activated neutrophils.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20220108      PMCID: PMC2850955          DOI: 10.1177/1933719110361960

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  26 in total

1.  Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count.

Authors:  M Haeger; M Unander; B Norder-Hansson; M Tylman; A Bengtsson
Journal:  Obstet Gynecol       Date:  1992-01       Impact factor: 7.661

2.  Preeclampsia: an imbalance in placental prostacyclin and thromboxane production.

Authors:  S W Walsh
Journal:  Am J Obstet Gynecol       Date:  1985-06-01       Impact factor: 8.661

3.  Serum arachidonic acid levels in normal and preeclamptic pregnancies.

Authors:  P L Ogburn; P P Williams; S B Johnson; R T Holman
Journal:  Am J Obstet Gynecol       Date:  1984-01-01       Impact factor: 8.661

4.  The expression and activity of prostaglandin H synthase-2 is enhanced in trophoblast from women with preeclampsia.

Authors:  R D Johnson; Y Sadovsky; C Graham; E Y Anteby; K L Polakoski; X Huang; D M Nelson
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

5.  Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid.

Authors:  S Camandola; G Leonarduzzi; T Musso; L Varesio; R Carini; A Scavazza; E Chiarpotto; P A Baeuerle; G Poli
Journal:  Biochem Biophys Res Commun       Date:  1996-12-13       Impact factor: 3.575

6.  COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.

Authors:  N V Chandrasekharan; Hu Dai; K Lamar Turepu Roos; Nathan K Evanson; Joshua Tomsik; Terry S Elton; Daniel L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

7.  Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia.

Authors:  Courtney E Leik; Scott W Walsh
Journal:  Hypertension       Date:  2004-05-17       Impact factor: 10.190

8.  Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia.

Authors:  M A Williams; R W Zingheim; I B King; A M Zebelman
Journal:  Epidemiology       Date:  1995-05       Impact factor: 4.822

9.  Neutrophil activation in pregnancy-induced hypertension.

Authors:  I A Greer; N G Haddad; J Dawes; F D Johnstone; A A Calder
Journal:  Br J Obstet Gynaecol       Date:  1989-08

10.  Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells.

Authors:  T Ishizuka; M Kawakami; T Hidaka; Y Matsuki; M Takamizawa; K Suzuki; A Kurita; H Nakamura
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

View more
  7 in total

Review 1.  Pregnancy-specific expression of protease-activated receptor 1: a therapeutic target for prevention and treatment of preeclampsia?

Authors:  Scott W Walsh; Jerome F Strauss
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

2.  Gene Expression of Pregnancy Neutrophils Differs for Protease versus Lipopolysaccharide Stimulation.

Authors:  Scott W Walsh; Marwah Al Dulaimi; Jerome F Strauss
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

3.  Nitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a pre-eclampsia-associated gene.

Authors:  Ludivine Doridot; Laurent Châtre; Aurélien Ducat; Jean-Luc Vilotte; Anne Lombès; Céline Méhats; Sandrine Barbaux; Rosamaria Calicchio; Miria Ricchetti; Daniel Vaiman
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

4.  Preconditioning Contractions Suppress Muscle Pain Markers after Damaging Eccentric Contractions.

Authors:  Hiroshi Nagahisa; Kazumi Ikezaki; Ryotaro Yamada; Takashi Yamada; Hirofumi Miyata
Journal:  Pain Res Manag       Date:  2018-10-14       Impact factor: 3.037

Review 5.  The Road to Low-Dose Aspirin Therapy for the Prevention of Preeclampsia Began with the Placenta.

Authors:  Scott W Walsh; Jerome F Strauss
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

6.  Influence of serum HMW adiponectin level in patients with pregnancy-induced hypertension syndrome on the occurrence of eclampsia in secondary pregnancy.

Authors:  Qian Xu; Dongmei Fan; Fahong Li; Zhanhong Zhang
Journal:  Exp Ther Med       Date:  2017-09-07       Impact factor: 2.447

7.  MicroRNA‑144‑3p may participate in the pathogenesis of preeclampsia by targeting Cox‑2.

Authors:  Suwei Hu; Jie Li; Ming Tong; Qian Li; Yong Chen; Hongmei Lu; Yixiong Wang; Lingfeng Min
Journal:  Mol Med Rep       Date:  2019-04-11       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.